Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Pediatric Oncology

Building Your Care Team: The Power of Specialized Expertise

At a Glance

The gold standard for osteosarcoma treatment is care at a high-volume specialized sarcoma center by a multidisciplinary team. A dedicated team of pediatric and orthopedic oncologists working together improves survival rates and lowers the risk of the cancer returning.

Osteosarcoma is so rare that most local doctors and general surgeons may only see one case in their entire career. Because of this, the most critical decision you will make as a parent is choosing a high-volume specialized sarcoma center [1]. Research shows that patients treated at these centers have significantly better survival rates and a lower risk of the cancer returning [2][1].

The Multidisciplinary Team (MDT)

The “gold standard” for osteosarcoma care is a Multidisciplinary Team (MDT)—a group of experts from different medical fields who meet regularly to coordinate every step of your child’s treatment [2][3].

Your Team Roster

  • Pediatric Oncologist: The “quarterback” of the team. They manage the chemotherapy (MAP regimen) and monitor your child’s overall health, including heart and kidney function [4].
  • Orthopedic Oncologist: A surgeon who specializes specifically in bone and soft-tissue tumors. They are responsible for the biopsy and the definitive limb-salvage or amputation surgery [5][6].
  • Musculoskeletal (MSK) Radiologist: A radiologist with advanced training in reading bone scans. They are essential for precisely mapping the tumor’s size and its proximity to nerves and vessels [7].
  • Bone Pathologist: An expert who examines the tumor tissue under a microscope. Their job is to confirm the diagnosis and, after surgery, determine the Huvos grade (the percentage of tumor necrosis) [8][9].

Preparing for Your First Consultation

When you go to a specialized center for a first visit or a second opinion, you must bring the physical evidence of your child’s diagnosis. Having these “artifacts” ready prevents treatment delays and ensures the team has all the data they need [2][7].

The Essential Evidence Checklist:

  • [ ] Imaging on Disc: Every X-ray, MRI, CT, and PET scan your child has had. These must be the raw “DICOM” files on a CD or USB, not just the printed reports.
  • [ ] Pathology Slides: If a biopsy has already been performed, you must request the actual glass slides (and potentially the “block” of tissue) from the original hospital. A second review by a specialized bone pathologist is a critical safety step [2].
  • [ ] Clinical Records: A complete folder of your child’s medical history, including any procedure notes or blood work results [7].

Vetting Your Team

Do not be afraid to “interview” your medical team. A world-class sarcoma center will expect and welcome these questions.

Questions to Ask

  1. “How many children with osteosarcoma did this team treat in the last year?” (You are looking for a center that treats dozens, not just a handful).
  2. “Will my child’s surgery be performed by an orthopedic oncologist, and how many limb-salvage procedures do they do annually?”
  3. “Is there a dedicated sarcoma nurse coordinator who will be our primary point of contact?”
  4. “What is your team’s process for reviewing pathology? Do you have a specialized bone pathologist on-site?”

By ensuring your child is cared for by a specialized team following standardized protocols, you are giving them the best possible chance for a successful outcome [2][4][10].

Common questions in this guide

Why is it important to go to a specialized sarcoma center for osteosarcoma?
Osteosarcoma is extremely rare, so many general doctors may never see a case. Research shows that patients treated at high-volume specialized sarcoma centers have significantly better survival rates and a lower risk of the cancer returning.
What is a multidisciplinary team (MDT) for osteosarcoma?
A multidisciplinary team (MDT) is a group of experts from different medical fields who meet regularly to coordinate every step of treatment. For osteosarcoma, this is the gold standard of care and ensures all specialists are aligned on the treatment plan.
Who should be on my child's osteosarcoma care team?
The core team should include a pediatric oncologist to manage chemotherapy, an orthopedic oncologist for surgery, a musculoskeletal radiologist to read bone scans, and a specialized bone pathologist to examine tumor tissue.
What should I bring to our first osteosarcoma consultation?
You need to bring physical evidence of the diagnosis. This includes all imaging scans on a disc as raw DICOM files, the actual glass pathology slides from any biopsies, and a complete folder of clinical medical records.
Will the new hospital re-evaluate the original biopsy slides?
Yes, getting a second opinion on pathology is a critical safety step. A specialized sarcoma center will have their own dedicated bone pathologist review the actual glass slides from the original biopsy to confirm the exact diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does this hospital have a weekly multidisciplinary tumor board where our child's case will be discussed by the entire team?
  2. 2.How many cases of osteosarcoma does this specific surgical and oncology team treat each year?
  3. 3.Will our child's pathology slides be re-evaluated by a dedicated bone pathologist here?
  4. 4.Are there any pediatric-specific clinical trials currently open at this center for newly diagnosed patients?
  5. 5.Do you have dedicated psychosocial support and education specialists to help our child cope with the treatment process?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Surgery in reference centers improves survival of sarcoma patients: a nationwide study.

    Blay JY, Honoré C, Stoeckle E, et al.

    Annals of oncology : official journal of the European Society for Medical Oncology 2019; (30(7)):1143-1153 doi:10.1093/annonc/mdz124.

    PMID: 31081028
  2. 2

    PATIENTS WITH SOFT TISSUE SARCOMA AFTER TREATMENT BY NON ORTHOPEDIC ONCOLOGIC SURGEONS: EPIDEMIOLOGICAL PROFILE, STAGING, AND THERAPEUTIC CHALLENGES.

    do Couto FB, Yonamine ES, Magno FG, et al.

    Acta ortopedica brasileira 2026; (34(1)):e293900 doi:10.1590/1413-785220263401e293900.

    PMID: 41696555
  3. 3

    UK guidelines for the management of bone sarcomas.

    Gerrand C, Athanasou N, Brennan B, et al.

    Clinical sarcoma research 2016; (6()):7 doi:10.1186/s13569-016-0047-1.

    PMID: 27148438
  4. 4

    Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?-A Systematic Review and Meta-Analysis.

    Larios F, Gonzalez MR, Ruiz-Arellanos K, et al.

    Cancers 2024; (16(2)) doi:10.3390/cancers16020443.

    PMID: 38275885
  5. 5

    Long-term Outcomes of 3-dimensional-printed Cutting Guides for Long Bone Sarcoma Resection and Intercalary Allograft Reconstruction: An Updated Case Series.

    Butler ZR, Riley DJ, Gusho CA, et al.

    Orthopedics 2026; (49(1)):e76-e82 doi:10.3928/01477447-20260106-02.

    PMID: 41636431
  6. 6

    Surgical Treatment of Bone Sarcoma.

    Bläsius F, Delbrück H, Hildebrand F, Hofmann UK

    Cancers 2022; (14(11)) doi:10.3390/cancers14112694.

    PMID: 35681674
  7. 7

    Postoperative Imaging of Sarcomas.

    Tavare AN, Robinson P, Altoos R, et al.

    AJR. American journal of roentgenology 2018; (211(3)):506-518 doi:10.2214/AJR.18.19954.

    PMID: 29927329
  8. 8

    How Technology Is Improving the Multidisciplinary Care of Sarcoma.

    Schaefer IM, Hong K, Kalbasi A

    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2020; (40()):445-462 doi:10.1200/EDBK_280729.

    PMID: 32421448
  9. 9

    Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets.

    Baldauf MC, Orth MF, Dallmayer M, et al.

    Oncotarget 2018; (9(2)):1587-1601 doi:10.18632/oncotarget.20098.

    PMID: 29416716
  10. 10

    Time to treatment initiation in primary extremity sarcomas: Determinants and oncological outcomes in a tertiary LMIC cancer center.

    Murali A, Krishnan CK, Patel V, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(11)):110449 doi:10.1016/j.ejso.2025.110449.

    PMID: 40974754

This page provides educational information about building a specialized osteosarcoma care team. It does not replace professional medical advice. Always consult a specialized sarcoma team regarding your child's specific diagnosis and treatment plan.

Get notified when new evidence is published on Osteosarcoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.